NCT07885800

Brief Summary

Incidental gallbladder carcinoma :Incidence and clinical significance in specimens from routine cholecystectomies in sohag locality

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Sep 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress13%
Sep 2026May 2027

Study Start

First participant enrolled

September 20, 2026

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

October 14, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 21, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 21, 2027

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2027

Last Updated

October 21, 2026

Status Verified

September 1, 2026

Enrollment Period

8 months

First QC Date

October 14, 2026

Last Update Submit

October 14, 2026

Conditions

Keywords

gall bladder carcinoma

Outcome Measures

Primary Outcomes (1)

  • incidence of gallbladder carcinoma

    incidence of gallbladder carcinoma in histopathology

    6 months

Study Arms (1)

all patient performed cholecystectomy

Other: histopathology of gall bladder

Interventions

histopathology of gall bladder after cholycystectomy

all patient performed cholecystectomy

Eligibility Criteria

Age14 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will involve patients undergoing elective or emergency cholecystectomy at Sohag University Hospital for presumed benign gallbladder disease, including symptomatic cholelithiasis, acute calculous cholecystitis, chronic calculous cholecystitis, gallbladder mucocele, empyema, or gallbladder polyps without confirmed preoperative malignancy

You may qualify if:

  • Patients undergoing cholecystectomy either lap or open or lap converted into open.
  • Patients whose gallbladder specimens are available for complete histopathological examination.
  • Patients who provide written informed consent to participate in the study.
  • Patients of both sexes and all eligible adult age groups.

You may not qualify if:

  • Patients with preoperatively confirmed gallbladder carcinoma.
  • Patients undergoing cholecystectomy as part of planned oncological surgery for another malignancy.
  • Patients with missing, damaged, or inadequately preserved gallbladder specimens.
  • Patients with incomplete clinical or histopathological data.
  • Patients refusing participation or postoperative follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University

Sohag, Egypt

RECRUITING

MeSH Terms

Conditions

Gallbladder Neoplasms

Condition Hierarchy (Ancestors)

Biliary Tract NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsBiliary Tract DiseasesDigestive System DiseasesGallbladder Diseases

Central Study Contacts

yahia kh ahmed, master

CONTACT

yahia kh ahmed, master

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
yahia.abdelrasol@med.sohag.edu.eg

Study Record Dates

First Submitted

October 14, 2026

First Posted

October 21, 2026

Study Start

September 20, 2026

Primary Completion (Estimated)

May 21, 2027

Study Completion (Estimated)

May 22, 2027

Last Updated

October 21, 2026

Record last verified: 2026-09

Locations